Iron overload and prolonged ingestion of iron supplements: Clinical features and mutation analysis of hemochromatosis-associated genes in four cases

American Journal of Hematology

Volumn 81, Issue 10, 2006, Pages 760-767

  Barton, James C ^a,b,e   Lee, Pauline L ^c   West, Carol ^c   Bottomley, Sylvia S ^d  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e ACC   (United States)

Author keywords

Hemochromatosis; HFE; Iron therapy; Mutation; TFR2; Therapeutic phlebotomy

Indexed keywords

FERRITIN; IRON;

ADULT; AGED; ALAS2 GENE; ANEMIA; ARTICLE; BETA THALASSEMIA; CASE REPORT; CLINICAL FEATURE; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; EXON; FEMALE; FERRITIN BLOOD LEVEL; FPN1 GENE; GENE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HAMP GENE; HEMOCHROMATOSIS; HETEROZYGOSITY; HFE GENE; HJV GENE; HOMOZYGOSITY; HUMAN; INGESTION; IRON ABSORPTION; IRON OVERLOAD; MALE; MUTATIONAL ANALYSIS; PHENOTYPE; PHLEBOTOMY; PRIORITY JOURNAL; SPHEROCYTOSIS; TRF2 GENE;

ADULT; AGED; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; MUTATION;

EID: 33749550140     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20714     Document Type: Article

References (53)

1. Case Records of the Massachusetts General Hospital. Case 38512. N Engl J Med 1952;247:992-995.
2. Wallerstein RO, Robbins SL. Hemochromatosis after prolonged oral iron therapy in a patient with chronic hemolytic anemia. Am J Med 1953;14:256-260.
3. Case Records of the Massachusetts General Hospital. Case 44131. N Engl J Med 1958;258:652-661.
4. Byrd RB, Cooper T. Hereditary iron-loading anemia with secondary hemochromatosis. Ann Intern Med 1961;55:103-123.
5. Jandl JH, Dvidson CS, Abelmann WH, Macdonald RA. Hemochromatosis terminating in polycythemia and hepatoma, with observations on the natural history of hemochromatosis. N Engl J Med 1963;269:1054-1059.
6. Pletcher WD, Brody GL, Meyers MC. Hemochromatosis following prolonged iron therapy in a patient with hereditary non-spherocytic hemolytic anemia. Am J Med Sci 1963;246:27-34.
7. Case Records of the Massachusetts General Hospital. Case 56-1965. N Engl J Med 1965;273:1483-1491.
8. Turnberg LA. Excessive oral iron therapy causing haemochromatosis. Br Med J 1965;5446:1360.
9. Johnson BF. Hemochromatosis resulting from prolonged oral iron therapy. N Engl J Med 1968;278:1100-1101.
10. Wheby MS. Medicinal iron-induced hepatic cirrhosis: Reversal by phlebotomy: Studies on pathogenesis. Trans Am Clin Climatol Assoc 1977;89:100-108.
11. Hennigar GR, Greene WB, Walker EM, de Saussure C. Hemochromatosis caused by excessive vitamin iron intake. Am J Pathol 1979;96:611-623.
12. Jalihal SS, Barlow AM. Haemochromatosis following prolonged oral iron ingestion. J R Soc Med 1984;77:690-692.
13. Green P, Eviatar JM, Sirota P, Avidor I. Secondary hemochromatosis due to prolonged iron ingestion. Isr J Med Sci 1989;25:199-201.
14. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am J Med 1995;99:616-623.
15. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
16. Barton JC, McDonnell SM, Adams PC, et al.; Hemochromatosis Management Working Group. Management of hemochromatosis. Ann Intern Med 1998;129:932-939.
17. Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis 1999;25:147-155.
18. Barton JC, Lee PL, Bertoli LF, Beutler E. Iron overload in an African American woman with SS hemoglobinopathy and a promoter mutation in the X-linked erythroid-specific 5-aminolevulinate synthase (ALAS2) gene. Blood Cells Mol Dis 2005;34:226-228.
19. Lee P, Gelbart T, West C, Halloran C, Beutler E. Seeking candidate mutations that affect iron homeostasis. Blood Cells Mol Dis 2002;29:471-487.
20. Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis 2001;27:783-802.
21. Lee PL, Beutler E, Rao SV, Barton JC. Genetic abnormalities and juvenile hemochromatosis: Mutations of the HJV gene encoding hemojuvelin. Blood 2004;103:4669-4671.
22. Lee PL, Halloran C, West C, Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol Dis 2001;27:285-289.
23. Murphy KJ. 4,644 grammes of oral ferrous sulphate (over 19 years) without apparent damage. Med J Aust 1968;1:1051-1052.
24. Crosby WH. Hemochromatosis and hemolytic disease. Arch Intern Med 1980;140:894-895.
25. Bezwoda WR, Disler PB, Lynch SR, et al. Patterns of food iron absorption in iron-deficient white and Indian subjects and in venesected haemochromatotic patients. Br J Haematol 1976;33:425-436.
26. McDonnell SM, Preston BL, Jewell SA, et al. A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment. Am J Med 1999;106:619-624.
27. Bell H, Berg JP, Undlien DE, et al. The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol 2000;35:1301-1307.
28. Anand BS, Callender ST, Warner GT. Absorption of inorganic and haemoglobin iron in coeliac disease. Br J Haematol 1977;37:409-414.
29. Edwards CQ, Williams DM, Cartwright GE. Hereditary hypoceruloplasminemia. Clin Genet 1979;15:311-316.
30. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Archbold GP. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q J Med 1994;87:663-670.
31. Van Vlierberghe H, Langlois M, Delanghe J, et al. Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients. J Hepatol 2001;35:707-711.
32. Livesey KJ, Wimhurst VL, Carter K, et al. The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading. J Med Genet 2004;41:6-10.
33. Kasvosve I, Gordeuk VR, Delanghe JR, et al. Iron status in black persons is not influenced by haptoglobin polymorphism. Clin Chem Lab Med 2002;40:810-813.
34. Beutler E, Beutler L, Lee PL, Barton JC. The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol Dis 2004;33:344-345.
35. Lee PL, Ho NJ, Olson R, Beutler E. The effect of transferrin polymorphisms on iron metabolism. Blood Cells Mol Dis 1999;25:374-379.
36. Kasvosve I, Delanghe JR, Gomo ZA, et al. Transferrin polymorphism influences iron status in blacks. Clin Chem 2000;46:1535-1539.
37. Kato J, Fujikawa K, Kanda M, et al. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 2001;69:191-197.
38. Mims MP, Guan Y, Pospisilova D, et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 2005;105:1337-1342.
39. Smith MD, Pannacciulli IM. Absorption of inorganic iron from graded doses: Its significance in relation to iron absorption tests and mucosal block theory. Br J Haematol 1958;4:428-434.
40. Bothwell TH, Charlton RW, Cook JD, Finch CA. Iron Metabolism in Man. Oxford: Blackwell. 1979. pp 256-283.
41. Bezwoda WR, Bothwell TH, Charlton RW, et al. The relative dietary importance of haem and non-haem iron. S Afr Med J 1983;64:552-556.
42. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-1276.
43. Piperno A, Mariani R, Arosio C, et al. Haemochromatosis in patients with β-thalassaemia trait. Br J Haematol 2000;111:908-914.
44. Barry M, Scheuer PJ, Sherlock S, Ross CF, Williams R. Hereditary spherocytosis with secondary haemochromatosis. Lancet 1968;2:481-485.
45. Zimelman AP, Miller A. Primary hemochromatosis with hereditary spherocytosis. Arch Intern Med 1980;140:983-984.
46. Brandenberg JB, Demarmels BF, Lutz HU, Wuillemin WA. Hereditary spherocytosis and hemochromatosis. Ann Hematol 2002;81:202-209.
47. Ichiche M, Lacor P, Hoorens A, Vanden Brande J, Brussaard H, Vanstraelen D. Congenital spherocytosis with hereditary hemochromatosis without pathogenic mutations in the HFE gene. Eur J Intern Med 2004;15:460-462.
48. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15.
49. Koyama C, Wakusawa S, Hayashi H, et al. Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis. Haematologica 2005;90:302-307.
50. Le Gac G, Mons F, Jacolot S, Scotet V, Ferec C, Frebourg T. Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent. Br J Haematol 2004;125:674-678.
51. Barton JC, Lee PL. Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R. Acta Haematol 2005;115:102-105.
52. Barton JC, Acton RT, Rivers CA, et al. Genotypic and phenotypic heterogeneity of African Americans with primary iron overload. Blood Cells Mol Dis 2003;31:310-319.
53. Gordeuk V, Mukiibi J, Hasstedt SJ, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 1992;326:95-100.